Genetic Technologies Ltd (GTG.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Operating Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -13 | -1 | 0 | -3 | -47 |
| Net Acquisitions | 0 | 0 | 0 | -486 | 71 |
| Other Investing Activity | 192 | 0 | 80 | 0 | 3 |
| Investing Cash Flow | $179 | $-1 | $79 | $-489 | $28 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -336 | 0 | -166 | 0 | N/A |
| Common Stock Issued | 0 | 7,172 | N/A | 0 | N/A |
| Other Financing Activity | -64 | -852 | 0 | 0 | 0 |
| Financing Cash Flow | $-400 | $6,320 | $-166 | $0 | $N/A |
| Exchange Rate Effect | 67 | 146 | -89 | 111 | 141 |
| Beginning Cash Position | 10,481 | 5,045 | 7,945 | 11,733 | 11,350 |
| End Cash Position | 7,851 | 10,481 | 5,045 | 7,945 | 11,731 |
| Net Cash Flow | $-2,695 | $5,290 | $-2,809 | $-3,899 | $-30,303 |
| Free Cash Flow | |||||
| Capital Expenditure | -13 | -1 | 0 | -3 | -80 |
| Free Cash Flow | -13 | -1 | 0 | -3 | -80 |